Lisata Therapeutics Inc (LSTA)
2.77
-0.03
(-1.16%)
USD |
NASDAQ |
May 08, 15:22
Lisata Therapeutics Price to Book Value: 0.4779 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 0.4835 |
| May 06, 2024 | 0.4779 |
| May 03, 2024 | 0.4917 |
| May 02, 2024 | 0.5055 |
| May 01, 2024 | 0.4922 |
| April 30, 2024 | 0.471 |
| April 29, 2024 | 0.4744 |
| April 26, 2024 | 0.4568 |
| April 25, 2024 | 0.4589 |
| April 24, 2024 | 0.4882 |
| April 23, 2024 | 0.4572 |
| April 22, 2024 | 0.4606 |
| April 19, 2024 | 0.4658 |
| April 18, 2024 | 0.4917 |
| April 17, 2024 | 0.4796 |
| April 16, 2024 | 0.49 |
| April 15, 2024 | 0.4882 |
| April 12, 2024 | 0.5003 |
| April 11, 2024 | 0.5331 |
| April 10, 2024 | 0.5245 |
| April 09, 2024 | 0.521 |
| April 08, 2024 | 0.502 |
| April 05, 2024 | 0.5297 |
| April 04, 2024 | 0.521 |
| April 03, 2024 | 0.5245 |
| Date | Value |
|---|---|
| April 02, 2024 | 0.5314 |
| April 01, 2024 | 0.5347 |
| March 28, 2024 | 0.5383 |
| March 27, 2024 | 0.5624 |
| March 26, 2024 | 0.5474 |
| March 25, 2024 | 0.5657 |
| March 22, 2024 | 0.5521 |
| March 21, 2024 | 0.578 |
| March 20, 2024 | 0.5331 |
| March 19, 2024 | 0.5279 |
| March 18, 2024 | 0.5245 |
| March 15, 2024 | 0.5314 |
| March 14, 2024 | 0.5227 |
| March 13, 2024 | 0.5279 |
| March 12, 2024 | 0.5348 |
| March 11, 2024 | 0.559 |
| March 08, 2024 | 0.5469 |
| March 07, 2024 | 0.5279 |
| March 06, 2024 | 0.5335 |
| March 05, 2024 | 0.5383 |
| March 04, 2024 | 0.5589 |
| March 01, 2024 | 0.5348 |
| February 29, 2024 | 0.5055 |
| February 28, 2024 | 0.5348 |
| February 27, 2024 | 0.545 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0335
Minimum
Dec 29 2021
0.6675
Maximum
Jan 04 2022
0.2389
Average
0.1464
Median
Price to Book Value Benchmarks
| Becton Dickinson & Co | 2.651 |
| Edwards Lifesciences Corp | 7.204 |
| AIM ImmunoTech Inc | 2.222 |
| Protalix BioTherapeutics Inc | 2.503 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 0.8342 |
| Price | 2.77 |
| Earnings Yield | -93.14% |
| Market Cap | 23.01M |